Activation of diverse signaling pathways by Ex-vivo delivery of multiple cytokines for myocardial repair

Stem Cells and Development

Volumn 22, Issue 2, 2013, Pages 204-215

  Konoplyannikov, Mikhail ^a   Haider, Khawaja Husnain ^a   Lai, Vien Khach ^a   Ahmed, Rafeeq P H ^a   Jiang, Shujia ^a   Ashraf, Muhammad ^a  

^a UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CONNEXIN 43; CYTOKINE; GELATINASE B; HYDROGEN PEROXIDE; HYPOXIA INDUCIBLE FACTOR 1ALPHA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INDUCIBLE NITRIC OXIDE SYNTHASE; MITOGEN ACTIVATED PROTEIN KINASE; NETRIN 1; PROTEIN KINASE B; PROTEIN KINASE C; SECRETED FRIZZLED RELATED PROTEIN 1; SECRETED FRIZZLED RELATED PROTEIN 2; SECRETED FRIZZLED RELATED PROTEIN 4; SECRETED FRIZZLED RELATED PROTEIN 5; STAT3 PROTEIN; STROMELYSIN; WNT3 PROTEIN;

ACUTE HEART INFARCTION; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL PROTECTION; CONTROLLED STUDY; EX VIVO STUDY; FEMALE; HEART FUNCTION; HEART INFARCTION SIZE; HEART MUSCLE; HEART MUSCLE CELL; MUSCLE REGENERATION; NONHUMAN; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; UMBILICAL VEIN ENDOTHELIAL CELL;

ANIMALS; BLOTTING, WESTERN; CELL MOVEMENT; CELLS, CULTURED; CHEMOKINE CXCL12; CULTURE MEDIA, CONDITIONED; CYTOPROTECTION; FEMALE; GAP JUNCTIONS; GREEN FLUORESCENT PROTEINS; HEART FUNCTION TESTS; HEART VENTRICLES; HEPATOCYTE GROWTH FACTOR; HUMAN UMBILICAL VEIN ENDOTHELIAL CELLS; HUMANS; HYDROGEN PEROXIDE; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; IMMUNOHISTOCHEMISTRY; IN SITU NICK-END LABELING; INSULIN-LIKE GROWTH FACTOR I; MALE; MUSCLE DEVELOPMENT; MYOBLASTS, SKELETAL; MYOCARDIAL INFARCTION; MYOCYTES, CARDIAC; PLASMIDS; RATS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; TRANSFECTION; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

RATTUS;

EID: 84872470279     PISSN: 15473287     EISSN: 15578534     Source Type: Journal    
DOI: 10.1089/scd.2011.0575     Document Type: Article

References (44)

1. Singla DK. (2010). Stem cells in the infarcted heart. J Cardiovasc Transl Res 3:73-78.
2. Menasche P, AA Hagege, M Scorsin, B Pouzet, M Desnos, D Duboc, K Schwartz, JT Vilquin and JP Marolleau. (2001). Myoblast transplantation for heart failure. Lancet 357: 279-280. (Pubitemid 32120862)
3. Menasche P, O Alfieri, S Janssens, W McKenna, H Reichenspurner, L Trinquart, JT Vilquin, JP Marolleau, B Seymour, et al. (2008). The Myoblast Autologous Grafting in Ischemic Cardiomyopathy (MAGIC) trial: first randomized placebo-controlled study of myoblast transplantation. Circulation 117:1189-1200. (Pubitemid 351552018)
4. Wollert KC, GP Meyer, J Lotz, S Ringes-Lichtenberg, P Lippolt, C Breidenbach, S Fichtner, T Korte, B Hornig, et al. (2004). Intracoronary autologous bone-marrow cell transfer after myocardial infarction: the BOOST randomised controlled clinical trial. Lancet 364:141-148. (Pubitemid 38891685)
5. Atkins BZ, MT Hueman, J Meuchel, KA Hutcheson, DD Glower and DA Taylor. (1999). Cellular cardiomyoplasty improves diastolic properties of injured heart. J Surg Res 85:234-242. (Pubitemid 29372329)
6. Taylor DA, BZ Atkins, P Hungspreugs, TR Jones, MC Reedy, KA Hutcheson, DD Glower and WE Kraus. (1998). Regenerating functional myocardium: improved performance after skeletal myoblast transplantation. Nat Med 4:929-933. (Pubitemid 28364032)
7. Perez-Ilzarbe M, O Agbulut, B Pelacho, C Ciorba, E San Jose-Eneriz, M Desnos, AA Hagege, P Aranda, EJ Andreu, P Menasche and F Prosper. (2008). Characterization of the paracrine effects of human skeletal myoblasts transplanted in infarcted myocardium. Eur J Heart Fail 10:1065-1072.
8. Kajstura J, M Rota, B Whang, S Cascapera, T Hosoda, C Bearzi, D Nurzynska, H Kasahara, E Zias, et al. (2005). Bone marrow cells differentiate in cardiac cell lineages after infarction independently of cell fusion. Circ Res 96:127-137. (Pubitemid 40095762)
9. Uemura R, M Xu, N Ahmad and M Ashraf. (2006). Bone marrow stem cells prevent left ventricular remodeling of ischemic heart through paracrine signaling. Circ Res 98: 1414-1421. (Pubitemid 43948066)
10. Jujo K, M Ii and DW Losordo. (2008). EPC in neovascularization of infarcted myocardium. J Mol Cell Cardiol 45: 530-544.
11. Dawn B, AB Stein, K Urbanek, M Rota, B Whang, R Rastaldo, D Torella, XL Tang, A Rezazadeh, et al. (2005). Cardiac stem cells delivered intravascularly traverse the vessel barrier, regenerate infarcted myocardium, and improve cardiac function. Proc Natl Acad Sci USA 102:3766-3771. (Pubitemid 40354686)
12. Rota M, ME Padin-Iruegas, Y Misao, A De Angelis, S Maestroni, J Ferreira-Martins, E Fiumana, R Rastaldo, ML Arcarese, et al. (2008). Local activation or implantation of cardiac progenitor cells rescues scarred infarcted myocardium improving cardiac function. Circ Res 103:107-116.
13. Banfi A, ML Springer and HM Blau. (2002). Myoblastmediated gene transfer for therapeutic angiogenesis. Methods Enzymol 346:145-157. (Pubitemid 41103136)
14. Niagara MI, H Haider, S Jiang and M Ashraf. (2007). Pharmacologically preconditioned skeletal myoblasts are resistant to oxidative stress and promote angiomyogenesis via release of paracrine factors in the infarcted heart. Circ Res 100:545-555. (Pubitemid 46673264)
15. Ahmed RP, KH Haider, J Shujia, MR Afzal and M Ashraf. (2010). Sonic Hedgehog gene delivery to the rodent heart promotes angiogenesis via iNOS/netrin-1/PKC pathway. PLoS One 5:e8576.
16. Stagg MA, SR Coppen, K Suzuki, A Varela-Carver, J Lee, NJ Brand, S Fukushima, MH Yacoub and CM Terracciano. (2006). Evaluation of frequency, type, and function of gapjunctions between skeletal myoblasts overexpressing connexin43 and cardiomyocytes: relevance to cell transplantation. Faseb J 20:744-746. (Pubitemid 46671201)
17. Jiang S, H Haider, NM Idris, A Salim and M Ashraf. (2006). Supportive interaction between cell survival signaling and angiocompetent factors enhances donor cell survival and promotes angiomyogenesis for cardiac repair. Circ Res 99:776-784. (Pubitemid 44498311)
18. Lu G, HK Haider, S Jiang and M Ashraf. (2009). Sca-1 + stem cell survival and engraftment in the infarcted heart: dual role for preconditioning-induced connexin-43. Circulation 119:2587-2596.
19. Kim HW, HK Haider, S Jiang and M Ashraf. (2009). Ischemic preconditioning augments survival of stem cells via miR-210 expression by targeting caspase-8-associated protein 2. J Biol Chem 284:33161-33168.
20. Hahn JY, HJ Cho, HJ Kang, TS Kim, MH Kim, JH Chung, JW Bae, BH Oh, YB Park and HS Kim. (2008). Pre-treatment of mesenchymal stem cells with a combination of growth factors enhances gap-junction formation, cytoprotective effect on cardiomyocytes, and therapeutic efficacy for myocardial infarction. J Am Coll Cardiol 51:933-943.
21. Sutton KM, S Hayat, NM Chau, S Cook, J Pouyssegur, A Ahmed, N Perusinghe, R Le Floch, J Yang and M Ashcroft. (2007). Selective inhibition of MEK1/2 reveals a differential requirement for ERK1/2 signalling in the regulation of HIF-1 in response to hypoxia and IGF-1. Oncogene 26: 3920-3929. (Pubitemid 46884295)
22. Pedersen M, T Lö fstedt, J Sun, L Holmquist-Mengelbier, S Pahlman and L Rö nnstrand. (2008). Stem cell factor induces HIF-1alpha at normoxia in hematopoietic cells. Biochem Biophys Res Commun 377:98-103.
23. Ferrara N, HP Gerber and J LeCouter. (2003). The biology of VEGF and its receptors. Nat Med 9:669-676. (Pubitemid 36749215)
24. Gerber HP, AK Malik, GP Solar, D Sherman, XH Xiang, G Meng, K Hong, JC Marsters and N Ferrara. (2002). VEGF regulates haematopoietic stem cell survival by an internal autocrine loop mechanism. Nature 417:954-958. (Pubitemid 34716872)
25. Lee RJ, ML Springer, WE Blanco-Bose, R Shaw, PC Ursell and HM Blau. (2000). VEGF gene delivery to myocardium: deleterious effects of unregulated expression. Circulation 102:898-901.
26. Linke A, P Muller, D Nurzynska, C Casarsa, D Torella, A Nascimbene, C Castaldo, S Cascapera, M Bohm, et al. (2005). Stem cells in the dog heart are self-renewing, clonogenic, and multipotent and regenerate infarcted myocardium, improving cardiac function. Proc Natl Acad Sci USA 102: 8966-8971. (Pubitemid 40881062)
27. Madonna R, G Rokosh, R De Caterina and R Bolli. (2010). Hepatocyte growth factor/Met gene transfer in cardiac stem cells-potential for cardiac repair. Basic Res Cardiol 105: 443-452.
28. Tambara K, GU Premaratne, G Sakaguchi, N Kanemitsu, X Lin, H Nakajima, Y Sakakibara, Y Kimura, M Yamamoto, et al. (2005). Administration of control-released hepatocyte growth factor enhances the efficacy of skeletal myoblast transplantation in rat infarcted hearts by greatly increasing both quantity and quality of the graft. Circulation 112: I129-I134. (Pubitemid 41266664)
29. Iwasaki M, Y Adachi, T Nishiue, K Minamino, Y Suzuki, Y Zhang, K Nakano, Y Koike, J Wang, et al. (2005). Hepatocyte growth factor delivered by ultrasound-mediated destruction of microbubbles induces proliferation of cardiomyocytes and amelioration of left ventricular contractile function in Doxorubicin-induced cardiomyopathy. Stem Cells 23: 1589-1597. (Pubitemid 41741008)
30. Poppe A, P Golsong, B Blumenthal, R von Wattenwyl, P Blanke, F Beyersdorf, C Schlensak and M Siepe. (2011). Hepatocyte growth factor-transfected skeletal myoblasts to limit the development of post-infarction heart failure. Artif Organs 36:238-246.
31. Askari AT, S Unzek, ZB Popovic, CK Goldman, F Forudi, M Kiedrowski, A Rovner, SG Ellis, JD Thomas, et al. (2003). Effect of stromal-cell-derived factor 1 on stem-cell homing and tissue regeneration in ischaemic cardiomyopathy. Lancet 362:697-703. (Pubitemid 37101067)
32. Grunewald M, I Avraham, Y Dor, E Bachar-Lustig, A Itin, S Jung, S Chimenti, L Landsman, R Abramovitch and E Keshet. (2006). VEGF-induced adult neovascularization: recruitment, retention, and role of accessory cells. Cell 124:175-189. (Pubitemid 43069318)
33. Aharinejad S, D Abraham, P Paulus, K Zins, M Hofmann, W Michlits, M Gyongyosi, K Macfelda, T Lucas, et al. (2008). Colony-stimulating factor-1 transfection of myoblasts improves the repair of failing myocardium following autologous myoblast transplantation. Cardiovasc Res 79:395-404.
34. Bialas M, M Krupka, A Janeczek, N Rozwadowska, M Fraczek, J Kotlinowski, P Kucharzewska, B Lackowska and M Kurpisz. (2011). Transient and stable transfections of mouse myoblasts with genes coding for pro-angiogenic factors. J Physiol Pharmacol 6:219-228.
35. Blumenthal B, P Golsong, A Poppe, C Heilmann, C Schlensak, F Beyersdorf and M Siepe. (2011). Polyurethane scaffolds seeded with genetically engineered skeletal myoblasts: a promising tool to regenerate myocardial function. Artif Organs 34:E46-E54.
36. Heissig B, K Hattori, S Dias, M Friedrich, B Ferris, NR Hackett, RG Crystal, P Besmer, D Lyden, et al. (2002). Recruitment of stem and progenitor cells from the bone marrow niche requires MMP-9 mediated release of kit-ligand. Cell 109:625-637. (Pubitemid 34628725)
37. Sang QX. (1998). Complex role of matrix metalloproteinases in angiogenesis. Cell Res 8:171-177. (Pubitemid 128544277)
38. Steve E and Jones CJ. (2002). Secreted frizzled-related proteins: searching for relationships and patterns. BioEssays 24:811-820.
39. Mirotsou M, Z Zhang, A Deb, L Zhang, M Gnecchi, N Noiseux, H Mu, A Pachori and V Dzau. (2007). Secreted frizzled related protein 2 (Sfrp2) is the key Akt-mesenchymal stem cell-released paracrine factor mediating myocar-dial survival and repair. Proc Natl Acad Sci USA 104:1643-1648. (Pubitemid 46214644)
40. Zhang Z, A Deb, A Pachori, W He, J Guo, R Pratt and VJ Dzau. (2009). Secreted frizzled related protein 2 protects cells from apoptosis by blocking the effect of canonical Wnt3a. J Mol Cell Cardiol 46:370-377.
41. He W, L Zhang, A Ni, Z Zhang, M Mirotsou, L Mao, RE Pratt and VJ Dzau. (2010). Exogenously administered secreted frizzled related protein 2 (Sfrp2) reduces fibrosis and improves cardiac function in a rat model of myocardial infarction. Proc Natl Acad Sci USA 107:21110-21115.
42. Laeremans H, TM Hackeng,MA van Zandvoort, VL Thijssen, BJ Janssen, HC Ottenheijm, JF Smits and WM Blankesteijn. (2011). Blocking of frizzled signaling with a homologous peptide fragment of Wnt3a/Wnt5a reduces infarct expansion and prevents the development of heart failure after myocardial infarction. Circulation 124:1626-1635.
43. Formigli L, F Francini, A Tani, R Squecco, D Nosi, L Polidori, S Nistri, L Chiappini, V Cesati, et al. (2005). Morphofunctional integration between skeletal myoblasts and adult cardiomyocytes in coculture is favored by direct cell-cell contacts and relaxin treatment. Am J Physiol Cell Physiol 288:C795-C804. (Pubitemid 40395057)
44. Reinecke H, E Minami, V Poppa and CE Murry. (2004). Evidence for fusion between cardiac and skeletal muscle cells. Circ Res 94:e56-e60.